Nano bioceramics: Properties, applications, hydroxyapatite, nanohydroxyapatite and drug delivery
Case Studies in Chemical and Environmental Engineering,
Год журнала:
2024,
Номер
10, С. 100869 - 100869
Опубликована: Июль 29, 2024
Bone
is
the
second
organ
of
human
body
that
has
most
transplants.
The
concept
bone
repair
evolved
over
past
five
decades
and
known
as
third
generation
biomaterials.
During
integration
nanotechnology
with
bioceramics,
an
emerging
research
field
called
nanobioceramics
been
born
within
Due
to
chemical
similarity
mineral
content
bone,
are
included
in
definition
a
new
biomaterials
whose
main
purpose
create
microenvironment
improve
cellular
responses
leading
osteogenesis.
Hydroxyapatite
member
calcium
phosphate
family.
This
substance,
which
bioactive
biocompatible
compound,
considered
component
tissue.
structural
this
compound
it
widely
used
tissue
dental
orthopedic
applications.
Many
basic
properties
hydroxyapatite
can
be
improved
by
changing
scale
its
particles
nanoparticles.
Therefore,
recent
years,
various
methods
for
synthesis
nanohydroxyapatite
have
reported.
Using
different
characterization
methods,
quality
synthesized
nanostructures
checked.
In
addition
bone-related
fields,
also
carrier
transfer
materials,
including
drugs,
vitamins,
proteins.
article,
modern
times,
advances
biomedical
focusing
on
use
bioceramics
treatment
diseases,
function
vital
organs,
engineering
brought
hopes
regenerative
medicine.
Various
being
investigated
synthesize
bioceramic
materials
using
natural
synthetic
materials.
There
several
challenges
enable
cost-effective
material
minimize
rejection
biological
systems.
One
major
incorporating
foreign
into
systems
their
acceptance
reduce
humans
other
organisms
studying
immune
responses.
When
developing
ceramic
mechanical
one
important
parameters
humans.
evaluation
criteria
mechanical,
existing
approaches
play
crucial
role
validating
bioceramics.
State-of-the-art
techniques
Язык: Английский
Effect and investigating of oxygen / nitrogen on modified glassy carbon electrode chitosan/carbon nanotube and best detection of nicotine using Cyclic voltammetry measurement technique
Results in Chemistry,
Год журнала:
2024,
Номер
10, С. 101739 - 101739
Опубликована: Авг. 1, 2024
Язык: Английский
Biosurfactants: Properties, Applications and Emerging Trends
Chou‐Yi Hsu,
Zaid H. Mahmoud,
Uday Abdul‐Reda Hussein
и другие.
South African Journal of Chemical Engineering,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 1, 2025
Язык: Английский
Development of Vitex-derived polymer nanofibers using electrochemical sensors for the treatment of polycystic ovarian syndrome in rats as an animal model
Zaid H. Mahmoud,
Uday Abdul‐Reda Hussein,
Najwa Aljbory
и другие.
Biosensors and Bioelectronics X,
Год журнала:
2024,
Номер
unknown, С. 100570 - 100570
Опубликована: Дек. 1, 2024
Язык: Английский
The Effect of Hemoadsorption with CytoSorb on Severe COVID-19 Complications
General Reanimatology,
Год журнала:
2024,
Номер
20(4), С. 30 - 38
Опубликована: Сен. 6, 2024
The
aim
of
the
study
was
to
assess
effect
hemoadsorption
with
CytoSorb
on
inflammatory
response,
respiratory
failure,
and
mortality
in
patients
severe
novel
coronavirus
infection.
Materials
methods.
A
retrospective
single-center
cohort
comparative
hemoadsorbtion
using
therapy
included
data
from
124
COVID-19
ICU
patients.
Patients
were
divided
into
two
groups:
arm
(group
1,
N
=93)
control
without
2,
=31).
group
1
had
more
failure
at
baseline,
but
otherwise
comparable
2
terms
clinical
demographic
parameters.
R
esults.
After
hemoadsorption,
showed
significant
improvement
9
13
monitored
clinical,
instrumental,
laboratory
parameters:
fever
(P=0.005),
lactate
dehydrogenase
(LDH)
(
P
<0.001),
C-reactive
protein
(CRP)
IL-6
<0.001)
levels,
as
well
an
increase
SpO₂/FiO₂
ratio
=0.041),
leukocyte
count
lymphocyte
=0.003),
no
changes
SOFA
score
=0.068).
only
seen
a
reduction
=0.003).
Other
unfavorable,
such
decrease
=0.002),
inspiratory
oxygen
fraction
FiO₂
=0.001),
<0.05),
LDH
=0.038),
procalcitonin
=0.005),
3.0
7.0
(95%CI,
3.0–9.0)
=0.001).
all-cause
hospital
rate
37,63%
74.20%
2.
C
onclusion.
use
pathogenetic
targeting
hyperinflammatory
response
management
algorithm
complications
resulted
resolution
mortality.
Язык: Английский